Gestational Trophoblastic Disease
📧 Sign up to get email alerts when something new happens for Gestational Trophoblastic Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: ASk Questions in GYnecologic Oncology (ASQ-GYO) [NA]
Clinical trial ASk Questions in Gynecologic Oncology (ASQ-GYO), sponsored by Ira Winer, is currently recruiting and covers ovarian and endom…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Letrozole as a Prophylaxis From GTN for Complete Mole Patients [Phase 2, Phase 3]
Clinical trial update on using letrozole as prophylaxis for GTN in patients with complete mole disease, spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Camrelizumab Combined With Apatinib for Recurrent Resistant GTN [Phase 2]
Phase 2 trial evaluating camrelizumab with apatinib for recurrent resistant gestational trophoblastic disease has completed.
-
FDA approval · 2020-01-30FDA Approved: METHOTREXATE — Original Application (Chartwell RX, LLC)
FDA approvedChartwell RX, LLC's methotrexate product under an Original Application, making a new generic version of methotrexate available. …
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia [Phase 3]
Phase 3 trial assessing single-dose methotrexate and methotrexate plus actinomycin-D in low-risk gestational trophoblastic neoplasia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-04-30Clinical Trial Update: A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors
Completed clinical trial update assessing medical, emotional, and reproductive concerns in gestational trophoblastic disease survivors.
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia [Phase 2, Phase 3]
Clinical trial update on rescue regimen and high-dose methotrexate for persistent gestational trophoblastic neoplasia across Phase 2 and Pha…
-
FDA approval · 2017-03-07FDA Approved: METHOTREXATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for METHOTREXATE SODIUM from Fresenius Kabi USA, LLC.
-
FDA approval · 2016-12-20FDA Approved: TREXALL — Supplemental Application (Teva Women's Health, Inc.)
FDA approved a supplemental application for TREXALL (methotrexate) from Teva Women's Health, Inc.
-
CLINICAL_TRIALS research · 2016-09-08Clinical Trial Update: The French National Reference Centre of GTD
A recruiting clinical trial in France led by Hospices Civils de Lyon focuses on gestational trophoblastic disease and related trophoblastic …
-
CLINICAL_TRIALS research · 2014-12-08Clinical Trial Update: Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease
A clinical trial evaluating interferometric detection of human chorionic gonadotropin in gestational trophoblastic disease.
-
FDA approval · 2013-02-05FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA's supplemental application for methotrexate, enabling the marketing of a generic methotrexate product…
-
FDA approval · 2007-04-30FDA Approved: METHOTREXATE — Original Application (Accord Healthcare, Inc.)
The FDA approved Accord Healthcare's original application for Methotrexate (generic).